Delivery Order SPE2DB20D3104-SPE2DB21FV9F9
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,550.47 firm fixed-price delivery order is for the supply of Calcipotriene-Betameth DP Ointment, a specialized pharmaceutical product. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop...
- This federal contract award, valued at $1,629.06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Calcipotriene-Betameth DP Ointment 60GM, a pharmaceutical product. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 through November 2026....
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at $1,024.13, is for the delivery of 4554631885 CALCIPOTRIENE-BETAMETH DP OINT 60GM, a pharmaceutical product. The contract has a completion date of September 2, 2021 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., and both entities are for-profit organizations...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is a firm fixed price delivery order for the supply of a specific pharmaceutical product, CALCIPOTRIENE-BETAMETH DP OINT 60GM, with a ceiling value of $1,267.86 and an ultimate completion date of April 10, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, involves the delivery of Calcipotriene 0.005% Cream 60GM to the Defense Logistics Agency (DLA). The $1,078.78 Firm Fixed Price delivery order was issued under the company's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a wide range of pharmaceutical...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of Calcipotriene 0.005% Cream 120g. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $56,341.14 and a period of performance through March 13, 2025. The contract is not set aside for any specific business category. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of Calcipotriene 0.005% Solution 60mL, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $5,117.07 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,135.24 firm fixed-price delivery order is for the supply of CALCIPOTRIENE 0.005% SOLUTION 60ML, a pharmaceutical product. The contract has an ultimate completion date of March 7, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Calcipotriene 0.005% Solution 60ML. The $1,570.10 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order valued at $1,683.97 for the supply of Calcipotriene 0.005% Solution 60ML, a pharmaceutical product. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB21FV9F9Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of a 60 gram tube of the topical drug Calcipotriene-Betameth DP Ointment. The $5,107.63 firm fixed-price delivery order was issued on August 10, 2021 with a completion date of August 11, 2021. The contract award did not utilize any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC serves as the primary contracting vehicle for AmerisourceBergen to efficiently deliver essential medications and medical commodities to the Department of Defense and other federal agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.1k | 8/10/21 |